Oppenheimer Asset Management Inc. Acquires 3,813 Shares of Astera Labs, Inc. $ALAB

Oppenheimer Asset Management Inc. raised its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 72.7% in the 4th quarter, Holdings Channel reports. The firm owned 9,057 shares of the company’s stock after purchasing an additional 3,813 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Astera Labs were worth $1,507,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in ALAB. Assetmark Inc. increased its stake in shares of Astera Labs by 374.1% during the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after buying an additional 101 shares during the period. Wexford Capital LP bought a new stake in shares of Astera Labs in the third quarter valued at about $39,000. Hilltop National Bank raised its holdings in shares of Astera Labs by 100.0% in the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after acquiring an additional 100 shares in the last quarter. Aventura Private Wealth LLC bought a new stake in shares of Astera Labs in the fourth quarter valued at about $33,000. Finally, National Bank of Canada FI raised its holdings in shares of Astera Labs by 159.0% in the third quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after acquiring an additional 124 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Price Performance

ALAB opened at $215.69 on Wednesday. The business’s 50-day moving average is $140.72 and its two-hundred day moving average is $153.38. Astera Labs, Inc. has a 1 year low of $63.40 and a 1 year high of $262.90. The firm has a market capitalization of $36.94 billion, a PE ratio of 176.80, a price-to-earnings-growth ratio of 3.96 and a beta of 3.35.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The company had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same quarter in the previous year, the firm earned $0.33 earnings per share. The firm’s quarterly revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, sell-side analysts expect that Astera Labs, Inc. will post 1.48 EPS for the current year.

Analyst Ratings Changes

Several analysts recently weighed in on the company. Barclays set a $165.00 price objective on Astera Labs in a report on Thursday, January 15th. Stifel Nicolaus set a $236.00 price objective on Astera Labs in a report on Friday. Rothschild & Co Redburn assumed coverage on Astera Labs in a report on Friday. They issued a “neutral” rating and a $153.00 price objective for the company. Loop Capital assumed coverage on Astera Labs in a report on Thursday, March 5th. They issued a “buy” rating and a $250.00 price objective for the company. Finally, Royal Bank Of Canada restated an “outperform” rating and issued a $250.00 price objective on shares of Astera Labs in a report on Tuesday, April 21st. Fifteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $199.20.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q1 earnings and revenue beat consensus — EPS $0.61 vs. $0.54 est.; revenue $308.4M, up 93% year-over-year and above expectations, showing rapid top-line expansion. Astera Labs Q1 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised Q2 (FY26 Q2) guidance sharply — EPS guide of $0.680–0.700 vs. street ~$0.50 and revenue guidance ~$355–365M vs. ~$310M consensus, implying continued acceleration into the quarter. Q1 Press Release / Guidance
• Positive Sentiment: Company points to AI spending as a key growth driver and raised investor expectations that demand from hyperscalers and AI customers is sustaining strong order flow. Astera Labs jumps as AI spending buoys Q1 results, guidance
• Positive Sentiment: Product traction: new Scorpio X‑Series 320‑lane smart fabric switch now shipping to leading hyperscalers, supporting the company’s positioning in rack‑scale AI connectivity. Scorpio X-Series Product Release
• Positive Sentiment: Third‑party sentiment and coverage supportive — analysts have an average “Moderate Buy” and prominent commentators (e.g., Jim Cramer) publicly bullish ahead of/around the report, reinforcing investor interest. Analyst Rating Jim Cramer Comment
• Neutral Sentiment: Sector tailwinds: broader chip/semiconductor stocks rallied recently, which likely amplified the stock’s move as investors rotated into AI- and infrastructure-exposed names. Chip Stocks Rally

Insider Buying and Selling

In other Astera Labs news, General Counsel Philip Mazzara sold 10,000 shares of Astera Labs stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $107.77, for a total value of $1,077,700.00. Following the transaction, the general counsel owned 118,084 shares in the company, valued at $12,725,912.68. The trade was a 7.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Michael Truett Tate sold 12,001 shares of Astera Labs stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total value of $1,485,843.81. Following the completion of the transaction, the chief financial officer owned 192,083 shares in the company, valued at $23,781,796.23. This trade represents a 5.88% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 1,064,888 shares of company stock valued at $150,764,723 over the last three months. Corporate insiders own 12.50% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.